Evidence map›Paper›PMID 30276554›Full record

ArticleMolecular diagnosis & therapy2018

Molecular Testing in EBUS-TBNA Specimens of Lung Adenocarcinoma: A Study of Concordance Between Cell Block Method and Liquid-Based Cytology in Appraising Sample Cellularity and EGFR Mutations.

Daniele Magnini, Leonello Fuso, Francesco Varone, Ettore D'Argento, Maurizio Martini, Antonietta Pecoriello, Vincenzo Di Noia, Damiano Arciuolo, Guido Fadda, Guido Rindi and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular diagnosis & therapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Liquid biopsy for T790M mutation detection: A ray of hope?Lung India : official organ of Indian Chest Society
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Daniele MagniniUOC Pneumologia, Fondazione Policlinico "A. Gemelli" IRCSS, Università Cattolica del Sacro Cuore, Largo F. Vito 1, 00168, Rome, Italy. daniele.magnini@hotmail.it.ORCID http://orcid.org/0000-0001-5766-2353
Leonello FusoUOC Pneumologia, Fondazione Policlinico "A. Gemelli" IRCSS, Università Cattolica del Sacro Cuore, Largo F. Vito 1, 00168, Rome, Italy.
Francesco VaroneUOC Pneumologia, Fondazione Policlinico "A. Gemelli" IRCSS, Università Cattolica del Sacro Cuore, Largo F. Vito 1, 00168, Rome, Italy.
Ettore D'ArgentoUOC Oncologia, Fondazione Policlinico "A. Gemelli" IRCSS, Università Cattolica del Sacro Cuore, Largo F. Vito 1, 00168, Rome, Italy.
Maurizio MartiniUOC Istopatologia e Citodiagnosi, Fondazione Policlinico "A. Gemelli" IRCSS, Università Cattolica del Sacro Cuore, Largo F. Vito 1, 00168, Rome, Italy.
Antonietta PecorielloUOC Pneumologia, Fondazione Policlinico "A. Gemelli" IRCSS, Università Cattolica del Sacro Cuore, Largo F. Vito 1, 00168, Rome, Italy.
Vincenzo Di NoiaUOC Oncologia, Fondazione Policlinico "A. Gemelli" IRCSS, Università Cattolica del Sacro Cuore, Largo F. Vito 1, 00168, Rome, Italy.
Damiano ArciuoloUOC Istopatologia e Citodiagnosi, Fondazione Policlinico "A. Gemelli" IRCSS, Università Cattolica del Sacro Cuore, Largo F. Vito 1, 00168, Rome, Italy.
Guido FaddaUOC Istopatologia e Citodiagnosi, Fondazione Policlinico "A. Gemelli" IRCSS, Università Cattolica del Sacro Cuore, Largo F. Vito 1, 00168, Rome, Italy.
Guido RindiUOC Istopatologia e Citodiagnosi, Fondazione Policlinico "A. Gemelli" IRCSS, Università Cattolica del Sacro Cuore, Largo F. Vito 1, 00168, Rome, Italy.
Luca RicheldiUOC Pneumologia, Fondazione Policlinico "A. Gemelli" IRCSS, Università Cattolica del Sacro Cuore, Largo F. Vito 1, 00168, Rome, Italy.
Università Cattolica del Sacro Cuore · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeCytological endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) specimens of mediastinal lymph node metastasis are frequently used to perform concomitant diagnosis, staging and genetic testing in non-small-cell lung cancer (NSCLC). The purposes of this single-center retrospective study were to evaluate EBUS-TBNA samples' adequacy for molecular testing of epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK), and to analyze the concordance between the cell block method and liquid-based cytology (LBC) in appraising the sample cellularity and in detecting EGFR mutation. MATERIALS AND

methodsWe retrospectively examined 82 patients who underwent EBUS-TBNA from October 2012 to September 2015 and received a confirmed diagnosis of lymph node metastasis of lung adenocarcinoma. Each sample was processed using both cell block and LBC to carry out DNA analysis (adequacy criterion: tumor cell percentage > 25%) and EGFR mutation testing.

resultsFifty-four patients were male, 66 were current or former-smokers, and the median age was 67 years. The median size of sampled lymph nodes was 14.8 mm. Seventy-one and 66 samples were adequate to perform cell block and LBC, respectively. The κ-statistic (0.78) showed an excellent concordance. EGFR mutation was detected in eight patients using cell block and in seven using LBC, with a simple percentage agreement of 87.5%. ALK translocation was found in two patients.

conclusionsThis study demonstrates the feasibility of EGFR mutation analysis with both cell block and LBC, with an excellent concordance between the two methods. Considering that the majority of advanced NSCLCs are diagnosed on cytology specimens, LBC is feasible and needs to be implemented for ancillary tests (immunocytochemistry, molecular analysis).

Indexed as

AdultAgedAged, 80 and overAnaplastic Lymphoma KinaseCarcinoma, Non-Small-Cell LungEndosonographyErbB ReceptorsHumansLung NeoplasmsLymphatic MetastasisMaleMiddle AgedMutationRetrospective StudiesAnaplastic Lymphoma KinaseEGFR protein, humanErbB Receptors

Identifiers

PMID30276554
OpenAlexW2894689034

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.